与编程死亡-1/编程细胞死亡-连接1免疫疗法相结合的跨动脉化学栓塞治疗肝细胞癌:一篇小小的综述
Jingxin Yan1,2,3, Manjun Deng3,4, Shunyu Kong1,2
1Department of Interventional Therapies, Affiliated Hospital of Qinghai University, Xining, China.
ILIVER..
|July 10, 2025
概括
结合跨动脉化疗 (TACE) 与编程细胞死亡-1/编程细胞死亡-连接体1 (PD-1/PD-L1) 免疫疗法,有望改善肝细胞癌 (HCC) 患者的生存率. 仔细监测诸如超级进展等并发症是必不可少的.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 肝胆道癌症 肝胆道癌症
背景情况:
- 肝细胞癌 (HCC) 是一种普遍存在的全球性恶性瘤.
- 包括PD-1/PD-L1免疫疗法在内的全身疗法正在推进HCC治疗.
- 通过动脉化学栓塞 (TACE) 与免疫疗法相结合是积极研究的一个领域.
研究的目的:
- 审查目前关于TACE和PD-1/PD-L1免疫疗法组合治疗HCC的临床证据.
- 评估这种联合治疗方法的疗效和安全性.
主要方法:
- 对评估TACE和PD-1/PD-L1免疫疗法在HCC中的临床研究进行系统审查.
- 对报告的生存结果和不良事件的分析.
主要成果:
- 在TACE和PD-1/PD-L1免疫治疗的组合中,大多数HCC患者的生存结果都很好.
- 通过这种联合治疗策略,有可能改善患者的生存率.
结论:
- 将TACE与PD-1/PD-L1免疫疗法结合,为肝细胞癌提供了一个有前途的治疗选择.
- 超级进展是一种严重的并发症,需要认真考虑和进一步的机制性调查.
更多相关视频
09:49Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization
Published on: December 2, 2013
10.4K
05:31Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients
Published on: September 20, 2020
5.7K
相关概念视频
02:50Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K